Sarepta Therapeutics, Inc. (SRPT): Price and Financial Metrics


Sarepta Therapeutics, Inc. (SRPT): $120.25

-2.11 (-1.72%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SRPT to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

SRPT POWR Grades

  • SRPT scores best on the Quality dimension, with a Quality rank ahead of 71.46% of US stocks.
  • SRPT's strongest trending metric is Quality; it's been moving up over the last 179 days.
  • SRPT's current lowest rank is in the Sentiment metric (where it is better than 20.61% of US stocks).

SRPT Stock Summary

  • SRPT has a higher market value than 84.21% of US stocks; more precisely, its current market capitalization is $10,970,188,523.
  • Of note is the ratio of SAREPTA THERAPEUTICS INC's sales and general administrative expense to its total operating expenses; just 15.29% of US stocks have a lower such ratio.
  • SRPT's price/sales ratio is 12.52; that's higher than the P/S ratio of 90.7% of US stocks.
  • If you're looking for stocks that are quantitatively similar to SAREPTA THERAPEUTICS INC, a group of peers worth examining would be ONCT, SLDP, UBX, STRO, and EXAI.
  • SRPT's SEC filings can be seen here. And to visit SAREPTA THERAPEUTICS INC's official web site, go to www.sarepta.com.

SRPT Valuation Summary

  • In comparison to the median Healthcare stock, SRPT's price/sales ratio is 137.25% higher, now standing at 12.1.
  • SRPT's price/sales ratio has moved down 105.4 over the prior 243 months.

Below are key valuation metrics over time for SRPT.

Stock Date P/S P/B P/E EV/EBIT
SRPT 2023-01-30 12.1 24.6 -14.8 -15.7
SRPT 2023-01-27 12.3 25.0 -15.1 -15.9
SRPT 2023-01-26 12.5 25.4 -15.3 -16.1
SRPT 2023-01-25 12.3 25.1 -15.1 -16.0
SRPT 2023-01-24 12.9 26.2 -15.7 -16.6
SRPT 2023-01-23 12.9 26.1 -15.7 -16.6

SRPT Growth Metrics

    Its 2 year net cashflow from operations growth rate is now at -214.62%.
  • Its 4 year revenue growth rate is now at 1772.43%.
  • Its 4 year price growth rate is now at 266.98%.
Over the past 33 months, SRPT's revenue has gone up $495,214,000.

The table below shows SRPT's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 876.047 -262.28 -716.225
2022-06-30 835.184 -321.645 -506.631
2022-03-31 765.786 -363.976 -356.555
2021-12-31 701.887 -443.172 -418.78
2021-09-30 645.564 -588.381 -486.116
2021-06-30 600.082 -702.238 -634.471

SRPT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SRPT has a Quality Grade of C, ranking ahead of 59.75% of graded US stocks.
  • SRPT's asset turnover comes in at 0.231 -- ranking 185th of 682 Pharmaceutical Products stocks.
  • ORMP, AGIO, and JAZZ are the stocks whose asset turnover ratios are most correlated with SRPT.

The table below shows SRPT's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.231 0.864 -0.249
2021-06-30 0.213 0.868 -0.332
2021-03-31 0.201 0.872 -0.375
2020-12-31 0.186 0.883 -0.313
2020-09-30 0.190 0.886 -0.376
2020-06-30 0.192 0.879 -0.357

SRPT Price Target

For more insight on analysts targets of SRPT, see our SRPT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $118.39 Average Broker Recommendation 1.5 (Moderate Buy)

SRPT Stock Price Chart Interactive Chart >

Price chart for SRPT

SRPT Price/Volume Stats

Current price $120.25 52-week high $134.08
Prev. close $122.36 52-week low $61.28
Day low $118.74 Volume 1,080,445
Day high $122.86 Avg. volume 1,026,247
50-day MA $123.27 Dividend yield N/A
200-day MA $100.57 Market Cap 10.56B

Sarepta Therapeutics, Inc. (SRPT) Company Bio


Sarepta Therapeutics is a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases. The company was founded in 1980 and is based in Cambridge, Massachusetts.


SRPT Latest News Stream


Event/Time News Detail
Loading, please wait...

SRPT Latest Social Stream


Loading social stream, please wait...

View Full SRPT Social Stream

Latest SRPT News From Around the Web

Below are the latest news stories about SAREPTA THERAPEUTICS INC that investors may wish to consider to help them evaluate SRPT as an investment opportunity.

Can you now get a good deal on Sarepta Therapeutics Inc.’s shares?

The share price of Sarepta Therapeutics Inc. (NASDAQ:SRPT) rose to $124.47 per share on Thursday from $123.16. While Sarepta Therapeutics Inc. has overperformed by 1.06%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, SRPT rose by 81.15%, with highs and lows ranging from $134.08 to $61.28, […]

US Post News | January 27, 2023

3 Gene Editing Stocks With the Best Long-Term Potential

These gene editing stocks are likely to deliver massive gains ahead in the fast-evolving biotech space

Muslim Farooque on InvestorPlace | January 25, 2023

7 Biotech Stocks That Will Make You Rich in 10 Years

Although the health innovation space presents risks, the opportunities beckon a look at the biotech stocks that will make you rich in 10 years.

Josh Enomoto on InvestorPlace | January 18, 2023

Trading Sarepta Therapeutics Inc. Com SRPT With Integrated Risk Controls

Trading Sarepta Therapeutics Inc. Com SRPT With Integrated Risk Controls

Stock Traders Daily | January 16, 2023

Sarepta Therapeutics Reports Preliminary* Fourth Quarter and Full-Year 2022 Net Product Revenues

- The Company expects to exceed 2022 full-year guidance for net product revenues

GlobeNewswire | January 9, 2023

Read More 'SRPT' Stories Here

SRPT Price Returns

1-mo -3.68%
3-mo 16.04%
6-mo 13.42%
1-year 68.37%
3-year 4.28%
5-year 90.51%
YTD -7.20%
2022 43.90%
2021 -47.18%
2020 32.12%
2019 18.24%
2018 96.14%

Continue Researching SRPT

Want to see what other sources are saying about Sarepta Therapeutics Inc's financials and stock price? Try the links below:

Sarepta Therapeutics Inc (SRPT) Stock Price | Nasdaq
Sarepta Therapeutics Inc (SRPT) Stock Quote, History and News - Yahoo Finance
Sarepta Therapeutics Inc (SRPT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9015 seconds.